WHO said that the steroid dexamethasone has shown benefit in "severely ill" patients
It is important to reserve use of the steroid dexamethasone for the treatment only of serious cases of COVID-19, for which it has been shown to have a benefit, the head of the World Health Organization's emergencies programme said on Wednesday.
"It's exceptionally important in these cases that the drug is reserved for severely ill and critical patients who can benefit from this clearly," Mike Ryan told a briefing.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)